Lupus is a chronic autoimmune disease in which the immune system attacks healthy tissue throughout the body, and it overwhelmingly affects women. Nine out of ten adults diagnosed with lupus are female. The disease can target the skin, joints, kidneys, brain, heart, and lungs, producing symptoms that range from mild joint pain and fatigue to life-threatening organ damage. Because its symptoms overlap with many other conditions, lupus is notoriously difficult to diagnose, often taking years before a woman gets a clear answer.
Why Lupus Hits Women Harder
The lopsided sex ratio in lupus is not a coincidence. Estrogen, the primary female sex hormone, amplifies immune activity in women who are genetically susceptible to the disease. In lupus-prone immune cells, estrogen ramps up a signaling enzyme that drives T cells (a type of white blood cell) to become overactive. Those overactive T cells then push B cells to produce antibodies that mistakenly attack the body’s own tissues. This effect is dose-dependent: more estrogen means more immune activation. Critically, this overreaction doesn’t happen in healthy women’s T cells or in men’s T cells. Something about the immune cells in women with lupus makes them uniquely responsive to estrogen’s signal.
This hormonal link explains why lupus most commonly appears during the reproductive years, roughly between ages 15 and 44, when estrogen levels are highest. It also explains why disease flares often coincide with periods of elevated estrogen, such as the premenstrual phase of each cycle or during pregnancy. After menopause, as estrogen levels drop, the female-to-male ratio of lupus cases narrows from about 8:1 down to roughly 2:1.
Common Symptoms
Lupus symptoms tend to come and go in waves called flares. The most commonly reported signs include extreme fatigue that doesn’t improve with rest, painful and swollen joints (especially in the hands, wrists, and knees), hair loss, sensitivity to sunlight, unexplained fevers, skin rashes, and kidney problems. The classic “butterfly rash,” a redness that spreads across the cheeks and bridge of the nose, is one of the most recognizable signs, though not every woman with lupus develops it.
What makes lupus tricky is that no two cases look alike. One woman might deal primarily with joint pain and fatigue, while another develops kidney inflammation with few outward symptoms. Flares can be triggered by sun exposure, infections, stress, or hormonal shifts, and they can alternate with periods of remission where symptoms nearly disappear.
How Lupus Is Diagnosed
There is no single test that confirms lupus. Diagnosis relies on a combination of symptoms, physical findings, and blood work. The starting point is almost always an antinuclear antibody (ANA) test. About 98% of people with systemic lupus test positive for ANA, making it extremely sensitive. The catch is that 5 to 10% of healthy people also test positive, so a positive ANA alone doesn’t mean you have lupus.
If the ANA is positive, more specific blood tests help narrow things down. The anti-double-stranded DNA antibody (anti-dsDNA) is found in about 30% of lupus patients but in less than 1% of healthy individuals. The anti-Smith antibody appears in roughly 20% of people with lupus and is rarely found in other conditions. Under the current international classification system, a positive ANA at a certain threshold is the mandatory entry point, and then a scoring system that weighs clinical symptoms and lab results determines the diagnosis. A score of 10 or more, with at least one clinical criterion met, confirms the classification.
Because the diagnostic process involves ruling out other diseases and waiting for enough criteria to accumulate, many women spend months or years being told their symptoms are stress, fibromyalgia, or “nothing.” Keeping a symptom diary and seeking a rheumatologist’s evaluation can shorten that timeline considerably.
Kidney Disease and Other Complications
Kidney involvement, called lupus nephritis, is one of the most serious complications. In a large study tracking over 8,500 lupus cases in Hong Kong across 20 years, 56% developed kidney disease at some point during their illness. Early kidney damage often produces no pain or obvious symptoms. It may only show up as protein in the urine or a gradual decline in kidney function detected through blood tests, which is why regular monitoring is essential for anyone living with lupus.
Beyond the kidneys, lupus can inflame the lining around the heart and lungs, cause blood clots, damage blood vessels, and affect the nervous system. Cardiovascular disease is a leading cause of death in women with lupus, partly because the chronic inflammation accelerates the buildup of plaque in arteries.
Pregnancy and Lupus
Women with lupus can have successful pregnancies, but they face higher risks than the general population. Flares sometimes occur during pregnancy, and complications including preeclampsia (dangerously high blood pressure), preterm labor, pregnancy loss, emergency cesarean delivery, excessive bleeding after delivery, and blood clots in the legs or lungs are all more common. Babies born to mothers with lupus are also more likely to arrive early and at a lower birth weight.
Some women with lupus carry antiphospholipid antibodies, proteins that increase the risk of miscarriage and stillbirth. Testing for these antibodies is a standard part of preconception planning. The strongest predictor of a healthy pregnancy is having the disease, and especially any kidney involvement, in stable remission on medications that are safe during pregnancy before conceiving.
Menopause and Hormone Therapy
Many women wonder whether menopause brings relief. Disease activity does tend to ease as estrogen declines, but lupus doesn’t simply disappear. A more practical concern is whether menopausal hormone therapy is safe. The evidence is mixed but leans toward caution. A large population-based study found that using hormone therapy increased the risk of developing lupus by about 30%, and systemic estrogen-progestogen combinations raised the risk by 50 to 90% compared with women who never used it. For women who already have lupus, hormone therapy has been linked to mild-to-moderate flares.
Interestingly, oral contraceptives in women with stable, low-activity lupus have not been consistently linked to flares in randomized trials. The key distinction appears to be disease stability: women with active or severe disease face greater hormonal risk than those in remission.
Treatment and Outlook
Lupus treatment aims to control flares, prevent organ damage, and maintain quality of life. Most women take some combination of anti-inflammatory medications, antimalarials (which calm the overactive immune system and reduce flares), and immunosuppressive drugs for more severe disease. Biologic therapies that target specific immune pathways are now available. One such treatment, originally approved for adults in 2011, was expanded in 2024 to include a home-injectable formulation for younger patients, reflecting the broader trend toward making lupus care less disruptive to daily life.
The prognosis for women with lupus has improved dramatically over the past several decades. The current 10-year survival rate for adult women with systemic lupus is approximately 93%. Early diagnosis, consistent monitoring for kidney and cardiovascular involvement, and staying on treatment even during remission are the factors most strongly associated with long-term survival. Lupus is a disease that requires lifelong management, but most women with it live full, active lives.